$3.40
-0.27[-7.36%]
At close: Apr 25
$3.40
0[0.00%]
PreMarket: 9:17AM EDT
Alimera Sciences
(NASDAQ:ALIM)Latest News for Alimera Sciences Stock (NASDAQ:ALIM)
Alimera Sciences Stock (NASDAQ: ALIM)
Categories: All
Monday, March 25, 2024
Tuesday, March 19, 2024
Friday, March 08, 2024
Thursday, March 07, 2024
- Alimera Sciences Expects 2024 Revenue Over $105M Vs. $103.66M Consensus, And Greater Than 20% Adjusted EBITDA MarginBenzinga Newsdesk - Mar 7, 2024, 7:40AM
- Alimera Sciences Q4 EPS $(0.07) Up From $(0.54) YoY, Sales $26.31M Beat $24.34M EstimateBenzinga Newsdesk - Mar 7, 2024, 7:32AM
- Earnings Scheduled For March 7, 2024Benzinga Insights - Mar 7, 2024, 4:49AM
Wednesday, March 06, 2024
Thursday, February 08, 2024
Thursday, January 04, 2024
Tuesday, January 02, 2024
Wednesday, November 29, 2023
- Chief Financial Officer & SVP at Alimera Sciences Acquires Company Stock Options Worth 50,000 SharesBenzinga Insights - Nov 29, 2023, 10:01AM
- Chief Operating Officer & SVP at Alimera Sciences Acquires Company Stock Options Worth 147,000 SharesBenzinga Insights - Nov 29, 2023, 10:01AM
- Alimera Sciences Chief Marketing Officer & SVP Awarded $302K Worth of Stock OptionsBenzinga Insights - Nov 29, 2023, 10:01AM
Tuesday, October 31, 2023
Thursday, October 26, 2023
Wednesday, October 11, 2023
Thursday, October 05, 2023
Tuesday, October 03, 2023
Monday, August 14, 2023
Thursday, August 10, 2023
Wednesday, August 09, 2023
Monday, June 12, 2023
- Alliance Global Partners Upgrades Alimera Sciences: Here's What You Need To KnowBenzinga Insights - Jun 12, 2023, 1:00PM
- Alimera Sciences shares are trading higher after Alliance Global Partners upgraded the stock from Neutral to Buy and raised its price target from $4.5 to $8.Benzinga Newsdesk - Jun 12, 2023, 12:20PM
- Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023Benzinga Insights - Jun 12, 2023, 11:00AM
- 10 Short Squeeze Stocks To Watch: Getty Images, Intuitive Machines, Wearable Devices & MoreChris Katje - Jun 12, 2023, 10:34AM
- Expert Ratings for Alimera SciencesBenzinga Insights - Jun 12, 2023, 10:03AM
- Alliance Global Partners Upgrades Alimera Sciences to Buy, Raises Price Target to $8Benzinga Newsdesk - Jun 12, 2023, 8:18AM
Friday, June 09, 2023
Thursday, May 25, 2023
Wednesday, May 24, 2023
Friday, May 19, 2023
- Why Foot Locker Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day SessionLisa Levin - May 19, 2023, 1:21PM
- 4 Analysts Have This to Say About Alimera SciencesBenzinga Insights - May 19, 2023, 1:01PM
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - May 19, 2023, 9:06AM
- Why DXC Technology Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving PremarketLisa Levin - May 19, 2023, 8:17AM
- HC Wainwright & Co. Maintains Buy on Alimera Sciences, Lowers Price Target to $5Benzinga Newsdesk - May 19, 2023, 6:20AM
Thursday, May 18, 2023
- 12 Health Care Stocks Moving In Thursday's Intraday SessionBenzinga Insights - May 18, 2023, 1:31PM
- Why Monro Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday's Mid-Day SessionLisa Levin - May 18, 2023, 1:19PM
- US Stocks Mixed; Jobless Claims Drop More than ProjectedLisa Levin - May 18, 2023, 9:56AM
- Alimera Sciences shares are trading higher after the company announced it acquired U.S. commercial rights to YUTIQ.Benzinga Newsdesk - May 18, 2023, 9:07AM
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - May 18, 2023, 9:07AM
- EyePoint Pharmaceuticals Announces Sale Of YUTIQ To Alimera Sciences For $82.5M Cash Plus RoyaltiesBenzinga Newsdesk - May 18, 2023, 7:04AM
- EyePoint Pharma Offloads Its Commercially-Available Eye Implant For $82.5M Plus RoyaltiesVandana Singh - May 18, 2023, 7:02AM